UNAIDS Welcomes US Move to Expand HIV Prevention Access
By Staff Reporter UNAIDS welcomes the announcement by the US State Department that the President’s Emergency Plan for AIDS Relief (PEPFAR) will be supporting an initiative by the Global Fund to Fight AIDS, TB and Malaria to provide lenacapavir to up to 2 million people in countries with high burdens of HIV. Lenacapavir, an American-based
Read MoreChina Firm Plans World’s First Pregnancy Humanoid Robot Using Artificial Womb
A Chinese tech firm is racing to deliver what could be the world’s first “gestation robot.” Kaiwa Technology, based in Guangzhou, has unveiled plans for a humanoid robot designed with an artificial womb embedded in its abdomen, capable of carrying a fetus through ten months of gestation and delivering a baby, according to Chinese media
Read More
China Deploys Drones and Mosquito Nets Amid Chikungunya Outbreak
By Michael Gwarisa China has launched an aggressive response to a Chikungunya virus outbreak that has infected over 7,000 people, mainly in Foshan, Guangdong Province. The mosquito-borne virus, which causes fever and severe joint pain, has led to hospitalizations lasting up to a week. In a COVID-style response, authorities have deployed drones to locate mosquito
Read MoreWHO Warns Against Using Antibiotics to Treat COVID-19 or Flu
By Michael Gwarisa The World Health Organization (WHO) has issued updated guidelines strongly advising against the use of antibiotics to treat COVID-19 or influenza, emphasizing that these medications are ineffective against viral infections and contribute to the growing threat of antimicrobial resistance (AMR). The guidelines, outlined in a recent WHO evidence brief, stress that antibiotics
Read MoreU.S. Senate Moves to Protect PEPFAR Funding Amid Trump-Era Cuts Threat
By Health Times Correspondent The International AIDS Society (IAS) has applauded a bipartisan effort in the U.S. Senate to safeguard the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) from a proposed $400 million funding cut that had originated from President Donald Trump’s rescission package. However, advocates caution that the battle is far from over.
Read MoreWHO Recommends Twice-Yearly Injectable Lenacapavir as Game-Changer in HIV Prevention
By Michael Gwarisa In a landmark move that could transform the global fight against HIV, the World Health Organization (WHO) today issued new guidelines endorsing the use of injectable lenacapavir (LEN) administered twice a year as an additional pre-exposure prophylaxis (PrEP) option. The announcement was made at the 13th International AIDS Society Conference (IAS 2025)
Read MoreGilead’s Secrecy Over HIV Prevention Shot Sparks Global Outrage
By Staff Reporter Gilead Sciences has come under fire after announcing a secretive deal to supply its long-acting injectable HIV prevention drug, lenacapavir (LEN-LA), to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The agreement—shrouded in indefinite price secrecy—has been widely condemned by civil society organisations, health advocates, and global health experts who warn
Read More
WHO Report launched last week warrants stronger measures to save lives from deadly tobacco and nicotine products and hold industry liable
By Staff Reporter The WCTC Declaration calls upon the governments of the world to accelerate the implementation of all measures under the WHO FCTC in order to end the tobacco epidemic. Among other actions, it urges countries to: “Recognise the tobacco industry as the biggest barrier to global progress in tobacco control. Reject engagements with
Read MoreFDA approves twice-a-year injection for HIV prevention
CNN — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.
Read More
New Form of Diabetes Recognised as Type 5 by Global Health Experts
The International Diabetes Federation (IDF) has officially designated malnutrition-related diabetes as “type 5 diabetes”, marking a significant step in addressing a long-overlooked health condition. The decision was made on 8 April 2025 during the IDF’s World Diabetes Congress in Bangkok, Thailand. This recognition aims to raise awareness of a disease that disproportionately affects young people in
Read More